COVID-19: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Jose Loyola (talk | contribs) |
||
| (23 intermediate revisions by 3 users not shown) | |||
| Line 26: | Line 26: | ||
==[[COVID-19 screening|Screening]]== | ==[[COVID-19 screening|Screening]]== | ||
==[[COVID-19 vaccines|Vaccines]]== | |||
==[[COVID-19 Variants of Concern|Variants of Concern]]== | |||
==[[COVID-19 natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ==[[COVID-19 natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ||
Prognosis can be made with findings on admission using https://rsconnect.biostat.jhsph.edu/covid_predict/ .<ref name="GaribaldiFiksel2020">{{cite journal|last1=Garibaldi|first1=Brian T.|last2=Fiksel|first2=Jacob|last3=Muschelli|first3=John|last4=Robinson|first4=Matthew L.|last5=Rouhizadeh|first5=Masoud|last6=Perin|first6=Jamie | |||
|last7=Schumock|first7=Grant|last8=Nagy|first8=Paul|last9=Gray|first9=Josh H.|last10=Malapati|first10=Harsha|last11=Ghobadi-Krueger|first11=Mariam|last12=Niessen|first12=Timothy M.|last13=Kim|first13=Bo Soo|last14=Hill|first14=Peter M.|last15=Ahmed|first15=M. Shafeeq|last16=Dobkin|first16=Eric D.|last17=Blanding|first17=Renee|last18=Abele|first18=Jennifer|last19=Woods|first19=Bonnie|last20=Harkness|first20=Kenneth|last21=Thiemann|first21=David R.|last22=Bowring|first22=Mary G.|last23=Shah|first23=Aalok B.|last24=Wang|first24=Mei-Cheng|last25=Bandeen-Roche|first25=Karen|last26=Rosen|first26=Antony|last27=Zeger|first27=Scott L.|last28=Gupta|first28=Amita|title=Patient Trajectories Among Persons Hospitalized for COVID-19|journal=Annals of Internal Medicine|year=2020|issn=0003-4819|doi=10.7326/M20-3905}}</ref> | |||
<div style="-moz-column-count:3; column-count:3;"> | <div style="-moz-column-count:3; column-count:3;"> | ||
| Line 46: | Line 51: | ||
===Dermatologic Complications=== | ===Dermatologic Complications=== | ||
* [[COVID-19-associated dermatologic manifestations]] | * [[COVID-19-associated dermatologic manifestations]] | ||
* [[COVID-19-associated alopecia]] | |||
===Gastrointestinal and Hepatic Complications=== | ===Gastrointestinal and Hepatic Complications=== | ||
| Line 70: | Line 76: | ||
* [[COVID-19-associated acute kidney injury]] | * [[COVID-19-associated acute kidney injury]] | ||
* [[COVID-19-associated hemodialysis]] | * [[COVID-19-associated hemodialysis]] | ||
* [[COVID-19 Infection in | * [[COVID-19 Infection in transplant patients]] | ||
===Neurologic Complications=== | ===Neurologic Complications=== | ||
| Line 86: | Line 92: | ||
:* [[COVID-19-associated myelitis]] | :* [[COVID-19-associated myelitis]] | ||
:* [[COVID-19-associated polyneuritis cranialis]] | :* [[COVID-19-associated polyneuritis cranialis]] | ||
===Psychiatric Complications=== | |||
* [[COVID-19-associated psychiatric disorders]] | |||
===Pulmonary Complications=== | ===Pulmonary Complications=== | ||
| Line 97: | Line 106: | ||
===Endocrine Complications=== | ===Endocrine Complications=== | ||
* [[COVID-19-associated diabetes mellitus]] | * [[COVID-19-associated diabetes mellitus]] | ||
* [[COVID-19 in diabetics]] | |||
* [[COVID-19-associated thyroid diseases]] | |||
===Pediatric Complications=== | ===Pediatric Complications=== | ||
* [[COVID-19-associated multisystem inflammatory syndrome]] | * [[COVID-19-associated multisystem inflammatory syndrome]] | ||
*[[Pediatrics and COVID-19|COVID-19 associated pediatric complications]] | *[[Pediatrics and COVID-19|COVID-19 associated pediatric complications]] | ||
===Long COVID syndrome=== | |||
*[[Long COVID|Long COVID]] | |||
</div> | </div> | ||
| Line 106: | Line 120: | ||
==Diagnosis== | ==Diagnosis== | ||
[[COVID-19 diagnostic study of choice|Diagnostic study of choice]] | [[COVID-19 history and symptoms|History and Symptoms]] | [[COVID-19 physical examination|Physical Examination]] | [[COVID-19 laboratory findings|Laboratory Findings]] | [[COVID-19 electrocardiogram|Electrocardiogram]] | [[COVID-19 x ray|X-Ray Findings]] | [[COVID-19 echocardiography and ultrasound|Echocardiography and Ultrasound]] | [[COVID-19 CT scan|CT-Scan Findings]] | [[COVID-19 MRI|MRI Findings]] | [[COVID-19 other imaging findings|Other Imaging Findings]] | [[COVID-19 other diagnostic studies|Other Diagnostic Studies]] | [[COVID-19 diagnostic study of choice|Diagnostic study of choice]] | [[COVID-19 history and symptoms|History and Symptoms]] | [[COVID-19 physical examination|Physical Examination]] | [[COVID-19 laboratory findings|Laboratory Findings]] | [[COVID-19 electrocardiogram|Electrocardiogram]] | [[COVID-19 x ray|X-Ray Findings]] | [[COVID-19 echocardiography and ultrasound|Echocardiography and Ultrasound]] | [[COVID-19 CT scan|CT-Scan Findings]] | [[COVID-19 MRI|MRI Findings]] | [[COVID-19 other imaging findings|Other Imaging Findings]] | [[COVID-19 other diagnostic studies|Other Diagnostic Studies]] | ||
The Cochrane Collaboration has reviewed both the [[COVID-19 history and symptoms|History and Symptoms]] | [[COVID-19 physical examination|Physical Examination]]<ref name="pmid33620086">{{cite journal| author=Struyf T, Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Leeflang MM | display-authors=etal| title=Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19. | journal=Cochrane Database Syst Rev | year= 2021 | volume= 2 | issue= | pages= CD013665 | pmid=33620086 | doi=10.1002/14651858.CD013665.pub2 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=33620086 }} </ref>. | |||
==Treatment== | ==Treatment== | ||
[[COVID-19 medical therapy|Medical Therapy]] | [[COVID-19 interventions|Interventions]] | [[COVID-19 surgery|Surgery]] | [[COVID-19 primary prevention|Primary Prevention]] | [[COVID-19 secondary prevention|Secondary Prevention]] | [[COVID-19 cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[COVID-19 future or investigational therapies|Future or Investigational Therapies]] | [[COVID-19 medical therapy|Medical Therapy]] | [[COVID-19 non-medical therapy|Non-medical Therapy]] | [[COVID-19 interventions|Interventions]] | [[COVID-19 surgery|Surgery]] | [[COVID-19 primary prevention|Primary Prevention]] | [[COVID-19 secondary prevention|Secondary Prevention]] | [[COVID-19 cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[COVID-19 future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
[[COVID-19 case study one|Case #1]] | [[COVID-19 case study one|Case #1]] | ||
==External links== | |||
Emerging evidence and knowledge | |||
* Australian National COVID-19 Clinical Evidence Taskforce, https://covid19evidence.net.au/ | |||
* CORD-19, https://www.semanticscholar.org/cord19 | |||
* COVID-END, https://www.mcmasterforum.org/networks/covid-end | |||
* COVID-19 Knowledge Accelerator, https://www.gps.health/covid19_knowledge_accelerator.html | |||
* COVID-NMA, https://covid-nma.com/ | |||
[[Category: Infectious disease]] | [[Category: Infectious disease]] | ||
==References== | |||
{{reflist|2}} | |||
Latest revision as of 15:00, 17 August 2022
|
COVID-19 Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
COVID-19 On the Web |
|
American Roentgen Ray Society Images of COVID-19 |
For COVID-19 frequently asked outpatient questions, click here.
For COVID-19 frequently asked inpatient questions, click here.
For COVID-19 patient information, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sabawoon Mirwais, M.B.B.S, M.D.[2], Syed Hassan A. Kazmi BSc, MD [3] COVID-19 Project Team
Synonyms and keywords: Novel coronavirus, covid-19, COVID-19, SARS-CoV-2, Wuhan coronavirus
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating COVID-19 from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Vaccines
Variants of Concern
Natural History, Complications and Prognosis
Prognosis can be made with findings on admission using https://rsconnect.biostat.jhsph.edu/covid_predict/ .[1]
Cardiovascular Complications
- COVID-19-associated myocardial injury
- COVID-19-associated myocarditis
- COVID-19-associated myocardial infarction
- COVID-19-associated heart failure
- COVID-19-associated arrhythmia and conduction system disease
- COVID-19-associated cardiogenic shock
- COVID-19-associated cardiac arrest
- COVID-19-associated pericarditis
- COVID-19-associated spontaneous coronary artery dissection
- COVID-19-associated stress cardiomyopathy
Dermatologic Complications
Gastrointestinal and Hepatic Complications
- COVID-19-associated digestive symptoms
Hematologic Complications
- COVID-19-associated coagulopathy
- COVID-19-associated cytokine storm
- COVID-19-associated hematologic symptoms
Infectious Disease Complications
Nephrologic Complications
- COVID-19-associated acute kidney injury
- COVID-19-associated hemodialysis
- COVID-19 Infection in transplant patients
Neurologic Complications
- COVID-19-associated CNS manifestations
- COVID-19-associated PNS manifestations
Psychiatric Complications
Pulmonary Complications
- COVID-19-associated acute respiratory distress syndrome
- COVID-19-associated hypoxemia
- COVID-19-associated pneumonia
- COVID-19-associated pulmonary embolism
- COVID-19-associated pulmonary hypertension
- COVID-19-associated respiratory failure
Endocrine Complications
Pediatric Complications
Long COVID syndrome
Diagnosis
Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies
The Cochrane Collaboration has reviewed both the History and Symptoms | Physical Examination[2].
Treatment
Medical Therapy | Non-medical Therapy | Interventions | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
External links
Emerging evidence and knowledge
- Australian National COVID-19 Clinical Evidence Taskforce, https://covid19evidence.net.au/
- CORD-19, https://www.semanticscholar.org/cord19
- COVID-END, https://www.mcmasterforum.org/networks/covid-end
- COVID-19 Knowledge Accelerator, https://www.gps.health/covid19_knowledge_accelerator.html
- COVID-NMA, https://covid-nma.com/
References
- ↑ Garibaldi, Brian T.; Fiksel, Jacob; Muschelli, John; Robinson, Matthew L.; Rouhizadeh, Masoud; Perin, Jamie; Schumock, Grant; Nagy, Paul; Gray, Josh H.; Malapati, Harsha; Ghobadi-Krueger, Mariam; Niessen, Timothy M.; Kim, Bo Soo; Hill, Peter M.; Ahmed, M. Shafeeq; Dobkin, Eric D.; Blanding, Renee; Abele, Jennifer; Woods, Bonnie; Harkness, Kenneth; Thiemann, David R.; Bowring, Mary G.; Shah, Aalok B.; Wang, Mei-Cheng; Bandeen-Roche, Karen; Rosen, Antony; Zeger, Scott L.; Gupta, Amita (2020). "Patient Trajectories Among Persons Hospitalized for COVID-19". Annals of Internal Medicine. doi:10.7326/M20-3905. ISSN 0003-4819.
- ↑ Struyf T, Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Leeflang MM; et al. (2021). "Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19". Cochrane Database Syst Rev. 2: CD013665. doi:10.1002/14651858.CD013665.pub2. PMID 33620086 Check
|pmid=value (help).